Early rehospitalizations have been well characterized in many disease states, but not among patients with cirrhosis. The aims of this study were to identify the frequency, costs, predictors, and preventable causes of hospital readmissions among patients with decompensated cirrhosis.
INTRODUCTION
Cirrhosis is the fi nal common pathway for the majority of liver diseases. More than 40,000 deaths in the United States each year can be attributed to complications of cirrhosis, nearly as many as attributable to diabetes and more than that attributable to kidney diseases ( 1 ) . Cirrhosis is also responsible for signifi cant morbidity and health-care costs. It leads to more than 150,000 hospitalizations costing nearly $ 4 billion dollars each year ( 2 ) , and the incidence of hospitalizations due to complications of cirrhosis is increasing ( 3 ) .
For patients with cirrhosis who survive their hospitalization, the period immediately aft er discharge is a high risk one. Th ey oft en carry new diagnoses, are on new medications or received changes in the dosages of existing medications, and are deconditioned from their hospital stay. Furthermore, responsibility for their care is typically being transitioned from the inpatient team to outpatient physicians, and communication between providers is not always optimal ( 4 ). For these reasons, clinical experience suggests that many patients are readmitted within the fi rst month.
In other chronic disease states, early hospital readmissions are widely recognized as being costly, associated with worse patient outcomes, and partially preventable ( 5 ) . For example, in the fi eld of congestive heart failure there have been multiple successful
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randomized trials of interventions to prevent hospital readmissions ( 6 ) . In cirrhosis, however, hospital readmissions have not been well characterized, and further information will be needed to design appropriate interventions. We hypothesized that early rehospitalizations among patients with cirrhosis are common and partially preventable. Th erefore, the aims of this study were to identify the frequency, cost, predictors, and preventable causes of hospital readmissions among patients with decompensated cirrhosis.
METHODS

Study sample
Th is was a retrospective study of adult (age ≥ 18 years) patients discharged from our institution between 1 July 2006 and 1 July 2009, and followed until liver transplant, death, lost to follow-up, or the end of the study period in August 2010. Potential subjects were initially identifi ed by discharge diagnoses including any of the following International classifi cation of diseases-9 or common procedure terminology codes: alcoholic cirrhosis (571.2), cirrhosis not due to alcohol (571.5), biliary cirrhosis (571.6), hepatic encephalopathy (572.2), ascites (789.59), hepatorenal syndrome (572.4), spontaneous bacterial peritonitis (567.23), esophageal varices with bleeding (456.0, 456.2), portal hypertension (572.3), hepatocellular carcinoma (155.0), other sequelae of chronic liver disease (572.8), or paracentesis (54.91). Overall, 1,926 individual patient charts were reviewed, and subjects were included if they had cirrhosis diagnosed by an attending hepatologist, along with any of the following complications as part of their hospital admission:
(1) Hepatic encephalopathy, defi ned as altered mental status diagnosed as hepatic encephalopathy by an attending hepatologist and improved aft er treatment with lactulose, (2) variceal hemorrhage, defi ned as a clinically signifi cant gastrointestinal bleed (tachycardia, hypotension, requirement for blood transfusion, or > 2 g drop in hemoglobin) and varices seen on endoscopy, (3) spontaneous bacterial peritonitis, defi ned as > 250 polymorphonuclear cells per high-power fi eld and / or monomicrobial culture in the ascitic fl uid, (4) renal failure in the presence of ascites, defi ned as a rise in the serum creatinine by 0.5 mg / dl (to > 1.5 mg / dl), with ascites documented on physical examination or ultrasound, or admitted on diuretics for the treatment of ascites, or (5) ascites requiring paracentesis during the hospitalization.
Exclusion criteria were (i) discharge with hospice care, and (ii) liver transplantation prior to or during the index hospitalization. Approval from the Institutional Review Board was obtained for the conduct of this study.
Institutional structure
Th is study was conducted at a single academic transplant center with nine hepatologists who see outpatients in a dedicated liver clinic, a core group of hepatology nursing staff , physician assistants available to see sick patients for urgent add-on visits, and a call center for patient calls. Procedures such as paracentesis are performed from Monday through Friday, and can typically be scheduled with 24 h notice. Th e catchment area is large, and many patients live up to 8 h ' drive away. On the inpatient side, patients with liver disease are either admitted to the dedicated liver service or are admitted to a general medicine service with hepatology consultation. On discharge, each patient is given a copy of the discharge summary. Th is document includes a summary of events during the hospitalization, pertinent test results, changes made to medications, medications on discharge, follow-up appointments, and list of warning symptoms that should prompt them to seek medical attention.
End points and statistical analysis
Subsequent hospital admissions were recorded aft er the index hospitalization by examining the computerized medical record at our institution for each patient. Th is record includes both inpatient (history and physical, daily notes, test results, and discharge summary) and outpatient documents. In order to capture episodes of hospitalization at other institutions, we examined all outpatient clinic and telephone notes that record hospital admissions (to any hospital) since the last clinic visit and notifi cations by patients, family members, or physicians at outside hospitals of any hospitalizations at other institutions. Follow-up time was censored at death, " elective " admissions such as transplant or post-procedure observation, or the date of the last clinic note. Admissions were categorized as elective if they were planned for a procedure or surgery. Th e primary end points included (i) time to fi rst readmission, and (ii) overall rate of readmissions during the study period. Statistical analysis was performed using Stata v.11 (StataCorp, College Station, TX).
Time to fi rst readmission was calculated using the Kaplan -Meier method, and predictors of time to readmission were determined using Cox regression. Th e following candidate predictors were fi rst analyzed individually: type of cirrhosis complication as described above, number of complications, being on the transplant list at discharge, length of hospital stay, discharge day of the week (weekday vs. weekend), number of medications on the discharge summary, discharge location (home vs. nursing facility), age, gender, race / ethnicity, marital status, insurance type (Medicaid or charity care vs. other), etiology of liver disease, presence of hepatocellular carcinoma, Charlson comorbidity index (calculated using the Deyo adaptation ( 7 )), and most recent laboratory values on discharge including Model for End-stage Liver Disease (MELD) score and serum sodium (both treated as continuous variables). Variables with P value < 0.1 were subsequently included in the multivariable model. Th e type of cirrhosis complication and number of complications were collinear, and neither was clearly superior in predictive power (by χ 2 -statistic), so number of complications was used in the fi nal model for simplicity. Th e fi nal multivariable model was then used to divide subjects into two equal groups based on their risk for early readmission, using the linear prediction of the fi tted model.
We hypothesized that factors infl uencing the fi rst readmission might be diff erent from those infl uencing multiple subsequent readmissions. Th erefore, negative binomial regression was used to determine which variables predicted hospitalization rate
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(hospitalizations / person-years at risk). As with the above analysis, elective admissions and those occurring aft er the time of transplantation were excluded.
In order to determine whether frequent rehospitalization was independently associated with mortality, we performed Cox regression on the hospitalization rate (readmissions / person-years), with censoring at the time of liver transplantation, lost to follow-up, or end of the study period. Potential confounders included in the model were the MELD score, age, number of medications, serum sodium, comorbidity index, and whether the patient was listed for transplant.
Costs were determined for readmissions within 1 week, and between weeks 1 and 4. Elective readmissions (including for transplant) were excluded. Costs were assessed using the University of Michigan cost accounting system (Transition Systems, TSI, Chicago, IL), and included both fi xed and variable costs. Th e TSI system tracks the use of all resources and assigns costs based on direct acquisition costs for supplies and time-and-motion studies for labor ( 8 ) .
Readmissions within 30 days were then assessed independently by two subspecialist physicians (MLV, MOR) and categorized as " possibly preventable " vs. " not preventable. " Th is determination was made by reviewing each discharge summary as well as the subsequent admission history and physical document, and any intervening clinic or phone notes. Readmissions were categorized as possibly preventable if there was evidence that a modifi cation to the health-care delivery system such as improved patient education, adherence to medications, or closer follow-up could have avoided that hospitalization. In order to avoid overestimating preventable readmissions, those that were unable to be accurately categorized (such as readmissions to an outside hospital) were categorized as not preventable. Concordance between the two reviewers was 83 % ; discrepancies were resolved by consensus and by categorizing admissions as not preventable when diff erences of opinion persisted. Th e most common discrepancy involved situations where the patient did not receive the care intended by the medical team, not because of miscommunication or inadequate education, but rather because the patient chose to be noncompliant or had inadequate social support to enact the care plan. Because these situations are not always necessarily modifi able, they were ultimately categorized as not preventable in the consensus results.
RESULTS
Four hundred and twenty-three subjects met eligibility criteria during the study period, but twenty one were excluded from further analysis due to lack of follow up at our institution aft er discharge. Clinical and demographic data from the index admission are displayed in Table 1 for the remaining 402 subjects who formed our study sample. Th e median time from hospital discharge to the end of the study period was 398 days, during which time 70 patients (17 % ) received a liver transplant and 83 (21 % ) others died.
Overall, 314 or 78 % of subjects were readmitted during the follow-up period, with 38 of them being elective in nature. Aft er censoring these elective readmissions, the median time to fi rst readmission was 67 days, as shown in Figure 1 , with 14 % of subjects readmitted within 1 week and 37 % readmitted within 1 month. Eighty-three percent of fi rst readmissions occurred at our institution, while 17 % were readmitted elsewhere. Th e median number of nonelective readmissions during the study period was 2 (range 0 -40) during a median time at risk of 203 days, yielding a median hospitalization rate of 3 hospitalizations / person-years. Among the 55 readmissions that occurred within 1 week, the mean cost per readmission was $ 25,898; among the 85 readmissions that occurred between weeks 1 and 4, the mean cost was $ 20,581.
Patients with more frequent readmissions had higher risk of subsequent mortality (hazard ratio 1.08 per unit increase in hospitalization rate, P < 0.001), despite adjustment for MELD score, serum sodium, number of medications, age, comorbidity index, and being listed for transplant. Independent predictors of time to fi rst nonelective readmission were MELD score, serum sodium, and number of medications on discharge, as shown in Table 2 . Th e multivariable Cox model had a c-statistic of 0.65, indicating moderate predictive ability. Th e linear prediction of the fi tted model was then used to divide the subject population into two groups of equal size, based on their risk for early nonelective readmission, as shown in Figure 2 . For example, a patient with MELD score of 12, serum sodium of 140 mmol / l, and 6 medications on discharge would have a 22 % predicted risk of readmission by 1 month, whereas a patient with MELD score of 20, serum sodium of 125 mmol / l, and 14 medications on discharge would have a 60 % predicted risk of readmission by 1 month.
Independent predictors of hospitalization rate (hospitalizations / person-years) were similar, and included MELD score, serum sodium, number of medications on discharge, number of cirrhosis complications, and being on the transplant list at discharge, as shown in Table 3 .
Of the 165 readmissions within 1 month, 36 (22 % ) were judged to be possibly preventable. Th e most common causes for possibly preventable readmissions were hepatic encephalopathy and fl uid imbalance (hyper-and hypovolemia). Reasons why these admissions were judged to be possibly preventable were as follows. (i) Failure to appropriately titrate lactulose -numerous chart examples were seen where the patient was not having adequate number of bowel movements, was not aware of the need to adjust the dose, did not notify the clinic for worsening symptoms, and was subsequently admitted for encephalopathy. (ii) Failure to plan ahead for paracentesis -patients would wait until severely symptomatic to call for paracentesis, and when this could not be scheduled right away, they would present to the emergency room and be admitted for treatment of tense ascites. (iii) Failure to recognize warning signs indicating over-diuresis -patients would be discharged on a new dose of diuretics, would experience rapid weight loss and present to the emergency room with hypovolemia 
DISCUSSION
Th is study found that early rehospitalizations among patients with decompensated cirrhosis are extremely common, with 37 % of patients being readmitted within 1 month of discharge at a cost of over $ 20,000 per admission. By comparison, this rate is higher than in the Medicare population (20 % ) ( 9 ) or the elderly heart failure population (25 % ) ( 10 ). Not only were hospital readmissions common and costly, they were also moderately predictable and partially preventable. Risk factors for readmission included severity of liver disease as measured by the MELD score and serum sodium, as well as complexity of medical regimen as measured by the number of medications. Th ese variables permitted stratifi cation of the patients into two equally sized groups at high risk (55 % readmitted within 30 days) and lower risk (22 % readmitted within 30 days). Among the 165 admissions within 30 days of discharge, nearly one-quarter could have been prevented by better patient understanding of their medication regimen or by more intensive outpatient monitoring. Finally, frequent rehospitalizations were associated with higher risk of mortality, independent of measures of disease severity such as the MELD score. Cirrhosis is a complex disease, and the multiple complications can be overwhelming for patients and their caregivers. Th ey must adjust medications frequently, oft en with unclear instruction or confl icting advice from multiple physicians. Among other tasks, they must obtain the necessary laboratory follow-up, deal with side eff ects of diuretics such as muscle cramps, and titrate their lactulose medication to the number of desired bowel movements per day. Th ey are required to know what prescription and over-the counter medications to avoid, and to follow the proper diet despite minimal education on how to do so. Finally, they must know when and how to seek medical attention for warning signs of impending complications. Our current episodic and uncoordinated system of health-care delivery is poorly structured for such patients with chronic disease ( 11 ) . For example, the use of structured discharge summaries has long been known to be associated with improved communication between hospital providers and outpatient physicians, yet these simple interventions are not always utilized ( 12 ) . Th is fact has been recognized in other disease states, such as congestive heart failure, where chronic disease management is included as a Class 1 recommendation in practice guidelines ( 13 ) . Th e fi ndings in this study suggest that similar eff orts should be made for the cirrhosis population.
Limitations of this study include its single center and retrospective nature. Factors infl uencing readmissions, such as patient education and social support, will need to be assessed in future prospective studies. Additionally, readmissions at other hospitals were captured by reviewing subsequent chart documentation in our system, and thus some could have been missed. Th e fact that we reviewed charts to capture outside hospital admissions may partially explain our fi ndings of a relatively high 37 % one-month readmission rate. By comparison, a recent study in patients with advanced liver disease found a 1-month readmission rate of 20 % , but did not include readmissions at other institutions ( 14 ) . Finally, our classifi cation of early readmissions as preventable was entirely subjective, although agreement between independent reviewers was 83 % . Th e true test of whether readmissions among patients with cirrhosis are preventable will be if implementation of disease management interventions can successfully decrease their frequency.
In conclusion, hospital readmissions among patients with decompensated cirrhosis are common, costly, moderately predictable, in some cases, possibly preventable, and independently associated with mortality. Th ese fi ndings support the development of disease management interventions to prevent rehospitalization.
